scispace - formally typeset
Journal ArticleDOI

Bone marrow as a potential source of hepatic oval cells.

TLDR
A stem cell associated with the bone marrow has epithelial cell lineage capability and a proportion of the regenerated hepatic cells were shown to be donor-derived.
Abstract
Bone marrow stem cells develop into hematopoietic and mesenchymal lineages but have not been known to participate in production of hepatocytes, biliary cells, or oval cells during liver regeneration. Cross-sex or cross-strain bone marrow and whole liver transplantation were used to trace the origin of the repopulating liver cells. Transplanted rats were treated with 2-acetylaminofluorene, to block hepatocyte proliferation, and then hepatic injury, to induce oval cell proliferation. Markers for Y chromosome, dipeptidyl peptidase IV enzyme, and L21-6 antigen were used to identify liver cells of bone marrow origin. From these cells, a proportion of the regenerated hepatic cells were shown to be donor-derived. Thus, a stem cell associated with the bone marrow has epithelial cell lineage capability.

read more

Citations
More filters
Journal ArticleDOI

Interaction of hepatic stellate cells with diverse types of immune cells: Foe or friend?

TL;DR: The diversity roles of immune cells in regulating the activation of HSCs during hepatic fibrogenesis are summarized, in which several producible mediators by H SCs play important roles in the interaction with them.
Patent

Adipose tissue derived stromal cells for the treatment of neurological disorders

TL;DR: In this article, the use of adipose tissue derived stromal cells for the treatment of neural injury (stroke, traumatic brain injury, spinal cord injury) and neurodegeneration (i.e. Parkinson's disease).
Journal ArticleDOI

Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes.

TL;DR: FGF2 facilitates the differentiation of transplanted BMCs into albumin-producing hepatocytes via Liv2-positive hepatoblast intermediates through the activation of TNF-α signaling.
BookDOI

Cell fusion in health and disease

TL;DR: Cell fusion in health and disease, Cell fusion in Health and disease , کتابخانه دیجیتال جندی شاپور اهواز
Journal ArticleDOI

Hepatic stem cells: from bone marrow cells to hepatocytes.

TL;DR: In this review, the interactions between hepatic stem cells are summarized and a hypothesis of hepatic differentiation will be proposed.
References
More filters
Journal ArticleDOI

Muscle Regeneration by Bone Marrow-Derived Myogenic Progenitors

TL;DR: Transplantation of genetically marked bone marrow into immunodeficient mice revealed that marrow-derived cells migrate into areas of induced muscle degeneration, undergo myogenic differentiation, and participate in the regeneration of the damaged fibers.
Journal Article

In vivo differentiation of rat liver oval cells into hepatocytes.

TL;DR: The data indicate that oval cells can differentiate to hepatocytes and may have an important physiological function as a source of major serum proteins when hepatocytes are unable to synthesize these proteins.
Journal ArticleDOI

Presence of hematopoietic stem cells in the adult liver

TL;DR: The data obtained from the mouse study strongly suggest that hematopoietic stem cells residing in the donor liver are responsible for mixed chimerism and maintenance of tolerance after liver transplantation.
Journal Article

Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat.

TL;DR: The SCF/c-kit system may, possibly in combination with other growth factor/receptor systems, be involved in the early activation of the hepatic stem cells as well as in the expansion and differentiation of oval cells.
Journal ArticleDOI

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats.

TL;DR: Both the GVHD propensity and tolerogenicity in these experiments were closely associated with recipient tissue chimerism 30 and 100 days after the experiments began, and these observations provide guidelines that should be considered in devising leukocyte augmentation protocols for human whole organ recipients.
Related Papers (5)